Definitive Healthcare实现了第四季度财报，但下调了2026年财报指引，导致其股价尽管现金和需求强劲，仍下跌。 Definitive Healthcare met Q4 earnings but lowered 2026 guidance, causing its stock to drop despite strong cash and demand.

Definitive Healthcare公布2025年第四季度调整后的每股收益为0.06美元，符合预期，收入为6153万美元，略高于预期。 Definitive Healthcare reported Q4 2025 adjusted EPS of $0.06, meeting expectations, and revenue of $61.53 million, slightly above estimates. 就Q1 2026而言,它预测EPS为0.03美元,低于0.05美元的共识,收入为5 400万美元-56 000万美元,低于预期的57 200万美元。 For Q1 2026, it projected EPS of $0.03, below the $0.05 consensus, and revenue of $54M–$56M, short of $57.2M expected. 2026年全年的EPS指导降低到0.14至0.17美元,低于2.21美元的共识。 Full-year 2026 EPS guidance was lowered to $0.14–$0.17, below the $0.21 consensus. 尽管流动性强劲——1.636亿美元现金,同比增长55%,而且需求稳定,但库存量大跌至1.40美元。 Despite strong liquidity—$163.6 million in cash, up 55% year-over-year—and stable demand, the stock dropped to $1.40 on heavy volume. 机构所有权仍然很高,达到98.67%,但分析师的前景参差不齐,有一致的“持股”评级,目标价格为3.94美元。 Institutional ownership remains high at 98.67%, but analysts maintain a mixed outlook, with a consensus “hold” rating and a target price of $3.94. 该公司通过云平台提供医疗数据分析。 The company provides healthcare data analytics via a cloud platform.